关注
Peter Hu
Peter Hu
在 mdanderson.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Comparative Sequence Analysis of Mycobacterium leprae and the New Leprosy-Causing Mycobacterium lepromatosis
XY Han, KC Sizer, EJ Thompson, J Kabanja, J Li, P Hu, L Gómez-Valero, ...
Journal of bacteriology 191 (19), 6067-6074, 2009
1472009
Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study
JC Nickel, S Herschorn, KE Whitmore, JB Forrest, P Hu, AJ Friedman, ...
The Journal of Urology 193 (3), 857-862, 2015
1392015
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in …
T Robak, J Jin, H Pylypenko, G Verhoef, N Siritanaratkul, J Drach, ...
The Lancet Oncology 19 (11), 1449-1458, 2018
1222018
Aberrant hnRNP K expression: all roads lead to cancer
M Gallardo, MJ Hornbaker, X Zhang, P Hu, C Bueso-Ramos, SM Post
Cell Cycle 15 (12), 1552-1557, 2016
992016
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
K Takahashi, F Wang, K Morita, Y Yan, P Hu, P Zhao, AA Zhar, CJ Wu, ...
Nature communications 9 (1), 2670, 2018
962018
Prognostic value of MYC rearrangement in cases of B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma
P Lin, TJ Dickason, LE Fayad, PA Lennon, P Hu, M Garcia, MJ Routbort, ...
Cancer 118 (6), 1566-1573, 2012
932012
MYC protein expression is an important prognostic factor in acute myeloid leukemia
M Ohanian, U Rozovski, R Kanagal-Shamanna, LV Abruzzo, S Loghavi, ...
Leukemia & lymphoma 60 (1), 37-48, 2019
712019
Randomized, double-blind, placebo-controlled, multicenter study of siltuximab in high-risk smoldering multiple myeloma
TA Brighton, A Khot, SJ Harrison, D Ghez, BM Weiss, A Kirsch, H Magen, ...
Clinical Cancer Research 25 (13), 3772-3775, 2019
642019
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
W Jiang, G Cai, PC Hu, Y Wang
Acta pharmaceutica sinica B 8 (4), 530-538, 2018
612018
Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients
AM Bolivar, R Luthra, M Mehrotra, W Chen, BA Barkoh, P Hu, W Zhang, ...
Modern Pathology 32 (3), 405-414, 2019
572019
Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma
G Huang, JD Krocker, JL Kirk, SN Merwat, H Ju, RD Soloway, LR Wieck, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 52 (6), 899-909, 2014
542014
Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation and peripheral artery disease: insights from the ARISTOTLE trial
PT Hu, RD Lopes, SR Stevens, L Wallentin, L Thomas, JH Alexander, ...
Journal of the American Heart Association 6 (1), e004699, 2017
502017
Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction
H Wu, H Chen, PC Hu
Clinical Laboratory 53 (5-6), 285-296, 2007
442007
Efficacy and safety of a single-dose mebendazole 500 mg chewable, rapidly-disintegrating tablet for Ascaris lumbricoides and Trichuris trichiura infection treatment in …
SA Silber, E Diro, N Workneh, Z Mekonnen, B Levecke, P Steinmann, ...
The American journal of tropical medicine and hygiene 97 (6), 1851, 2017
402017
Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next‐generation sequencing of thyroid nodules
W Ye, B Hannigan, S Zalles, M Mehrotra, BA Barkoh, MD Williams, ...
Cancer Cytopathology 127 (3), 146-160, 2019
392019
Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens
B Hannigan, W Ye, M Mehrotra, V Lam, A Bolivar, S Zalles, BA Barkoh, ...
Annals of Oncology 30 (6), 963-969, 2019
382019
Safety and efficacy of delayed release rabeprazole in 1-to 11-month-old infants with symptomatic GERD
S Hussain, J Kierkus, P Hu, D Hoffman, R Lekich, S Sloan, W Treem
Journal of pediatric gastroenterology and nutrition 58 (2), 226-236, 2014
362014
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice
B Lamothe, YJ Lai, L Hur, NM Orozco, J Wang, AD Campos, M Xie, ...
PloS one 7 (12), e51228, 2012
362012
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD 33 expression and in vitro response to …
H Khogeer, H Rahman, N Jain, EA Angelova, H Yang, A Quesada, CY Ok, ...
British Journal of Haematology 186 (4), 538-548, 2019
282019
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations
L Millecker, PA Lennon, S Verstovsek, B Barkoh, J Galbincea, P Hu, ...
Cancer genetics and cytogenetics 197 (1), 1-7, 2010
262010
系统目前无法执行此操作,请稍后再试。
文章 1–20